Goldman Sachs Group Inc Alector, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Alector, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 511,293 shares of ALEC stock, worth $951,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
511,293
Previous 388,395 31.64%
Holding current value
$951,004
Previous $1.76 Million 35.39%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$4.34 - $6.58 $533,377 - $808,668
122,898 Added 31.64%
511,293 $2.39 Million
Q2 2024

Aug 13, 2024
BUY
$4.19 - $6.23 $289,654 - $430,679
69,130 Added 21.65%
388,395 $1.76 Million
Q1 2024

May 15, 2024
BUY
$5.69 - $8.08 $189,886 - $269,645
33,372 Added 11.67%
319,265 $1.92 Million
Q4 2023

Feb 13, 2024
BUY
$3.77 - $8.39 $142,030 - $316,084
37,674 Added 15.18%
285,893 $2.28 Million
Q3 2023

May 14, 2024
SELL
$5.2 - $8.77 $195,904 - $330,400
-37,674 Reduced 13.18%
248,219 $1.61 Million
Q3 2023

Nov 14, 2023
SELL
$5.2 - $8.77 $303,009 - $511,036
-58,271 Reduced 19.01%
248,219 $1.61 Million
Q2 2023

May 14, 2024
SELL
$5.86 - $7.93 $205,955 - $278,707
-35,146 Reduced 10.29%
306,490 $1.84 Million
Q2 2023

Aug 14, 2023
SELL
$5.86 - $7.93 $205,955 - $278,707
-35,146 Reduced 10.29%
306,490 $1.84 Million
Q1 2023

May 14, 2024
SELL
$5.85 - $9.84 $1.02 Million - $1.71 Million
-173,948 Reduced 33.74%
341,636 $2.11 Million
Q1 2023

May 11, 2023
SELL
$5.85 - $9.84 $1.02 Million - $1.71 Million
-173,948 Reduced 33.74%
341,636 $2.11 Million
Q4 2022

May 14, 2024
SELL
$6.88 - $9.55 $355,751 - $493,811
-51,708 Reduced 9.11%
515,584 $4.76 Million
Q4 2022

Feb 13, 2023
SELL
$6.88 - $9.55 $355,751 - $493,811
-51,708 Reduced 9.11%
515,584 $4.76 Million
Q3 2022

May 14, 2024
BUY
$8.19 - $13.2 $1.21 Million - $1.95 Million
147,775 Added 35.23%
567,292 $5.37 Million
Q3 2022

Nov 10, 2022
BUY
$8.19 - $13.2 $1.21 Million - $1.95 Million
147,775 Added 35.23%
567,292 $5.37 Million
Q2 2022

May 14, 2024
BUY
$7.65 - $14.24 $1.02 Million - $1.9 Million
133,624 Added 46.74%
419,517 $4.26 Million
Q2 2022

Aug 15, 2022
BUY
$7.65 - $14.24 $1.36 Million - $2.54 Million
178,374 Added 73.97%
419,517 $4.26 Million
Q1 2022

May 16, 2022
SELL
$13.02 - $20.78 $2.11 Million - $3.37 Million
-162,179 Reduced 40.21%
241,143 $3.44 Million
Q4 2021

Feb 14, 2022
SELL
$19.35 - $25.54 $3.69 Million - $4.88 Million
-190,937 Reduced 32.13%
403,322 $8.33 Million
Q3 2021

Nov 10, 2021
BUY
$21.65 - $39.49 $12.9 Million - $23.5 Million
594,259 New
594,259 $13.6 Million

Others Institutions Holding ALEC

# of Institutions
168
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email